Vascular endothelial growth factor activates nuclear factor of activated T cells in human endothelial cells: A role for tissue factor gene expression

Molecular and Cellular Biology

Volumn 19, Issue 3, 1999, Pages 2032-2043

  Armesilla, Angel Luis ^a,b   Lorenzo, Elisa ^a   Del Arco, Pablo Gómez ^a   Martínez Martínez, Sara ^a   Alfranca, Arantzazu ^b   Redondo, Juan Miguel ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM IONOPHORE; CYCLOSPORIN A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PHORBOL ESTER; THROMBOPLASTIN; TRANSCRIPTION FACTOR AP 1; VASCULOTROPIN;

ARTICLE; CONTROLLED STUDY; DNA BINDING; ENDOTHELIUM CELL; GENE ACTIVATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; T LYMPHOCYTE ACTIVATION; UMBILICAL VEIN;

EID: 0033019518     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.3.2032     Document Type: Article

References (67)

1. Abedi, H., and I. Zachary. 1997. Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells. J. Biol. Chem. 272: 15442-15451.
2. Andersen, H. O., G. Madsen, B. G. Nordestgaard, B. F. Hansen, K. Kjeldsen, and S. Stender. 1994. Cyclosporin suppresses transplant arteriosclerosis in the aorta-allografted, cholesterol-clamped rabbit. Suppression preceded by decrease in arterial lipoprotein permeability. Arterioscler. Thromb. 14:944-950.
3. 2+ and von Willebrand factor release in human endothelial cells. Am. J. Pathol. 138:213-221.
4. Brown, L. F., M. Detmar, K. Claffey, J. A. Nagy, D. Feng, A. M. Dvorak, and H. F. Dvorak. 1997. Vascular permeabilty factor/vascular endothelial growth factor: A multifunctional angiogenic cytokine, p. 233-269. In G. A. Rosen (ed.), Regulation of angiogenesis. Birkhauser Verlag, Basel, Switzerland.
5. Cahill, M. A., R. Janknecht, and A. Nordheim. 1996. Signalling pathways: jack of all cascades. Curr. Biol. 6:16-19.
6. Carmeliet, P., V. Ferreira, G. Breier, S. Pollefeyt, L. Kieckens, M. Gertsenstein, M. Fahrig, A. Vandenhoeck, K. Harpal, C. Eberhardt, C. Declercq, J. Pawling, L. Moons, D. Collen, W. Risau, and A. Nagy. 1996. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435-439.
7. Carmeliet, P., N. Mackman, L. Moons, T. Luther, P. Gressens, V. I. Van, H. Demunck, M. Kasper, G. Breier, P. Evrard, M. Muller, W. Risau, T. Edgington, and D. Collen. 1996. Role of tissue factor in embryonic blood vessel development. Nature 383:73-75.
8. Carmeliet, P., L. Moons, M. Dewerchin, N. Mackman, T. Luther, G. Breier, V. Ploplis, M. Muller, A. Nagy, E. Plow, R. Gerard, T. Edgington, W. Risau, and D. Collen. 1997. Insights in vessel development and vascular disorders using targeted inactivation and transfer of vascular endothelial growth factor, the tissue factor receptor, and the plasminogen system. Ann. N. Y. Acad. Sci. 811:191-206.
9. Clauss, M., M. Gerlach, H. Gerlach, J. Brett, F. Wang, P. C. Familletti, Y. C. Pan, J. V. Olander, D. T. Connolly, and D. Stern. 1990. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J. Exp. Med. 172:1535-1545.
10. Cockerill, G. W., A. G. Bert, G. R. Ryan, J. R. Gamble, M. A. Vadas, and P. N. Cockerill. 1995. Regulation of granulocyte-macrophage colony-stimulating factor and E-selectin expression in endothelial cells by cyclosporin A and the T-cell transcription factor NFAT. Blood 86:2689-2698.
11. Crabtree, G. R., and N. A. Clipstone. 1994. Signal transmission between the plasma membrane and nucleus of T lymphocytes. Annu. Rev. Biochem. 63:1045-1083.
12. D'Angelo, G., I. Struman, J. Martial, and R. I. Weiner. 1995. Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin. Proc. Natl. Acad. Sci. USA 92:6374-6378.
13. de la Pompa, J. L., L. A. Timmerman, H. Takimoto, H. Yoshida, A. J. Elia, E. Samper, J. Potter, A. Wakeham, L. Marengere, B. L. Langille, G. R. Crabtree, and T. W. Mak. 1998. Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature 392:182-186.
14. Deng, T., and M. Karin. 1994. c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK. Nature 371: 171-175.
15. Deng, T., and M. Karin. 1993. JunB differs from c-Jun in its DNA-binding and dimerization domains, and represses c-Jun by formation of inactive heterodimers. Genes Dev. 7:479-490.
16. de Vries, C., J. A. Escobedo, H. Ueno, K. Houck, N. Ferrara, and L. T. Williams. 1992. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255:989-991.
17. Durand, D. B., J. P. Shaw, M. R. Bush, R. E. Replogle, R. Belagaje, and G. R. Crabtree. 1988. Characterization of antigen receptor response elements within the interleukin-2 enhancer. Mol. Cell. Biol. 8:1715-1724.
18. Ferrara, N., M. K. Carver, H. Chen, M. Dowd, L. Lu, K. S. O'Shea, B. L. Powell, K. J. Hillan, and M. W. Moore. 1996. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380: 439-442.
19. Ferrara, N., and S. T. Davis. 1997. The biology of vascular endothelial growth factor. Endocr. Rev. 18:4-25.
20. Gómez del Arco, P., S. Martínez-Martínez, V. Calvo, A. L. Armesilla, and J. M. Redondo. 1997. Antioxidants and AP-1 activation: a brief overview. Immunobiology 198:273-278.
21. Guo, D., Q. Jia, H. Song, R. S. Warren, and D. B. Donner. 1995. Vascular endothelial growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. J. Biol. Chem. 12:6729-6733.
22. Ho, A. M., J. Jain, A. Rao, and P. G. Hogan. 1994. Expression of the transcription factor NFATp in a neuronal cell line and in the murine nervous system. J. Biol. Chem. 269:28181-28186.
23. Holschermann, H., F. Durfeld, U. Maus, A. Bierhaus, K. Heidinger, J. Lohmeyer, P. P. Nawroth, H. Tillmanns, and W. Haberbosch. 1996. Cyclosporin A inhibits tissue factor expression in monocytes/macrophages. Blood 88:3837-3845.
24. Holschermann, H., O. Kohl, U. Maus, F. Durfeld, A. Bierhaus, P. P. Nawroth, J. Lohmeyer, H. Tillmanns, and W. Haberbosch. 1997. Cyclosporin A inhibits monocyte tissue factor activation in cardiac transplant recipients. Circulation 96:4232-4238.
25. Jain, J., E. Burgeon, T. M. Badalian, P. G. Hogan, and A. Rao. 1995. A similar DNA-binding motif in NFAT family proteins and the Rel homology region. J. Biol. Chem. 270:4138-4145.
26. Karin, M. 1995. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270:16483-16486.
27. Kim, K. J., B. Li, J. Winer, M. Armanini, N. Gillett, H. S. Phillips, and N. Ferrara. 1993. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362:841-844.
28. Kroll, J., and J. Waltenberger. 1997. The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells. J. Biol. Chem. 272:32521-32527.
29. Liu, J. 1993. FK506 and cyclosporin A, molecular probes for studying intracellular signal transduction. Immunol. Today 14:290-295.
30. Liu, Z. Y., R. K. Ganju, J. F. Wang, K. Schweitzer, B. Weksler, S. Avraham, and J. E. Groopman. 1997. Characterization of signal transduction pathways in human bone marrow endothelial cells. Blood 90:2253-2259.
31. Loh, C., J. A. Carew, J. Kim, P. G. Hogan, and A. Rao. 1996. T-cell receptor stimulation elicits an early phase of activation and a later phase of deactivation of the transcription factor NFAT1. Mol. Cell. Biol. 16:3945-3954.
32. Loh, C., K. T. Shaw, J. Carew, J. P. Viola, C. Luo, B. A. Perrino, and A. Rao. 1996. Calcineurin binds the transcription factor NFAT1 and reversibly regulates its activity. J. Biol. Chem. 271:10884-10891.
33. Lyakh, L., P. Ghosh, and N. R. Rice. 1997. Expression of NFAT-family proteins in normal human T cells. Mol. Cell. Biol. 17:2475-2484.
34. Mackman, N. 1995. Regulation of the tissue factor gene. FASEB J. 9:883-889.
35. Mackman, N. 1997. Regulation of the tissue factor gene. Thromb. Haemost. 78:747-754.
36. Mackman, N., K. Brand, and T. S. Edgington. 1991. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites. J. Exp. Med. 174:1517-1526.
37. Mackman, N., B. J. Fowler, T. S. Edgington, and J. H. Morrissey. 1990. Functional analysis of the human tissue factor promoter and induction by serum. Proc. Natl. Acad. Sci. USA 87:2254-2258.
38. Mantovani, A., F. Bussolino, and M. Introna. 1997. Cytokine regulation of endothelial cell function: from molecular level to the bedside. Immunol. Today 18:231-240.
39. Martínez-Martínez, S., P. Gómez del Arco, A. L. Armesilla, J. Aramburu, C. Luo, A. Rao, and J. M. Redondo. 1997. Blockade of T-cell activation by dithiocarbamates involves novel mechanisms of inhibition of nuclear factor of activated T cells. Mol. Cell. Biol. 17:6437-6447.
40. Millauer, B., V. S. Wizigmann, H. Schnurch, R. Martínez, N. P. Moller, W. Risau, and A. Ullrich. 1993. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72:835-846.
41. Moll, T., M. Czyz, H. Holzmuller, W. R. Hofer, E. Wagner, H. Winkler, F. H. Bach, and E. Hofer. 1995. Regulation of the tissue factor promoter in endothelial cells. Binding of NF kappa B-, AP-1-, and Sp1-like transcription factors. J. Biol. Chem. 270:3849-3857.
42. Munoz, C., M. C. Castellanos, A. Alfranca, A. Vara, M. A. Esteban, J. M. Redondo, and M. O. de Landázuri. 1996. Transcriptional up-regulation of intracellular adhesion molecule-1 in human endothelial cells by the antioxidant pyrrolidine dithiocarbamate involves the activation of activating protein-1. J. Immunol. 157:3587-3597.
43. Northrop, J. P., S. N. Ho, L. Chen, D. J. Thomas, L. A. Timmerman, G. P. Nolan, A. Admon, and G. R. Crabtree. 1994. NF-AT components define a family of transcription factors targeted in T-cell activation. Nature 369:497-502.
44. Oeth, P. A., G. C. Parry, C. Kunsch, P. Nantermet, C. A. Rosen, and N. Mackman. 1994. Lipopolysaccharide induction of tissue factor gene expression in monocytic cells is mediated by binding of c-Rel/p65 heterodimers to a kappa B-like site. Mol. Cell. Biol. 14:3772-3781.
45. Papapetropoulos, A., C. G. García, J. A. Madri, and W. C. Sessa. 1997. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J. Clin. Invest. 100:3131-3139.
46. Park, J., N. R. Yaseen, P. G. Hogan, A. Rao, and S. Sharma. 1995. Phosphorylation of the transcription factor NFATp inhibits its DNA binding activity in cyclosporin A-treated human B and T cells. J. Biol. Chem. 270: 20653-20659.
47. Petrak, D., S. A. Memon, M. J. Birrer, J. D. Ashwell, and C. M. Zacharchuk. 1994. Dominant negative mutant of c-Jun inhibits NF-AT transcriptional activity and prevents IL-2 gene transcription. J. Immunol. 153:2046-2051.
48. Quinn, T. P., K. G. Peters, V. C. De, N. Ferrara, and L. T. Williams. 1993. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc. Natl. Acad. Sci. USA 90:7533-7537.
49. Ranger, A. M., M. J. Grusby, M. R. Hodge, E. M. Gravallese, F. C. De la Brousse, T. Hoey, C. Mickanin, H. S. Baldwin, and L. H. Glimcher. 1998. The transcription factor NF-ATc is essential for cardiac valve formation. Nature 392:186-190.
50. Rao, A. 1994. NF-ATp: a transcription factor required for the co-ordinate induction of several cytokine genes. Immunol. Today 15:274-281.
51. Rao, A., C. Luo, and P. G. Hogan. 1997. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15:707-747.
52. Rao, L. V. 1992. Tissue factor as a tumor procoagulant. Cancer Metastasis Rev. 11:249-266.
53. Rousseau, S., F. Houle, J. Landry, and J. Huot. 1997. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene 15:2169-2177.
54. Ruff, V. A., and K. L. Leach. 1995. Direct demonstration of NFATp dephosphorylation and nuclear localization in activated HT-2 cells using a specific NFATp polyclonal antibody. J. Biol. Chem. 270:22602-22607.
55. Schreiber, S. L., and G. R. Crabtree. 1992. The mechanism of action of cyclosporin A and FK506. Immunol. Today 13:136-142.
56. Seetharam, L., N. Gotoh, V. Maru, G. Neufeld, S. Yamaguchi, and M. Shibuya. 1995. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene 10:135-147.
57. Senger, D. R. 1996. Molecular framework for angiogenesis: a complex web of interactions between extravasated plasma proteins and endothelial cell proteins induced by angiogenic cytokines. Am. J. Pathol. 149:1-7.
58. Shaw, K. T., A. M. Ho, A. Raghavan, J. Kim, J. Jain, J. Park, S. Sharma, A. Rao, and P. G. Hogan. 1995. Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells. Proc. Natl. Acad. Sci. USA 92:11205-11209.
59. Shibasaki, F., E. R. Price, D. Milan, and F. McKeon. 1996. Role of kinases and the phosphatase calcineurin in the nuclear shuttling of transcription factor NF-AT4. Nature 382:370-373.
60. 2- signals and immunosuppression. Nature 383:837-840.
61. Venkataraman, L., S. J. Burakoff, and R. Sen. 1995. FK506 inhibits antigen receptor-mediated induction of c-rel in B and T lymphoid cells. J. Exp. Med. 181:1091-1099.
62. Waltenberger, J., W. L. Claesson, A. Siegbahn, M. Shibuya, and C. H. Heldin. 1994. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J. Biol. Chem. 269:26988-26995.
63. Warren, R. S., H. Yuan, M. R. Matli, N. A. Gillett, and N. Ferrara.1995. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J. Clin. Invest. 95:1789-1797.
64. Waseem, N. H., and D. P. Lane. 1990. Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form. J. Cell Sci. 96:121-129.
65. Weiss, D. L., J. Hural, D. Tara, L. A. Timmerman, G. Henkel, and M. A. Brown. 1996. Nuclear factor of activated T cells is associated with a mast cell interleukin 4 transcription complex. Mol. Cell. Biol. 16:228-235.
66. Woronicz, J. D., A. Lina, B. J. Calnan, S. Szychowski, L. Cheng, and A. Winoto. 1995. Regulation of the Nur77 orphan steroid receptor in activation-induced apoptosis. Mol. Cell. Biol. 15:6364-6376.
67. Xia, P., L. P. Aiello, H. Ishii, Z. Y. Jiang, D. J. Park, G. S. Robinson, H. Takagi, W. P. Newsome, M. R. Jirousek, and G. L. King. 1996. Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J. Clin. Invest. 98:2018-2026.